BPP Leadership Team
 | Douglas R. Stephan Manager Invention, Capital Program Interface, Regulatory Pathway, Licensing Initiatives |
 | Kim A. Heidenreich, PhD - Neuropharmacology Chief Scientific Officer Professor Emeritus, University of Colorado School of Medicine Invention, Scientific Platform, IP, Regulatory Pathway, Clinical Trial program initiatives |
 | Paul B. Dumond Member Invention, Scientific Platform, IP, Patent, Payer Reimbursement Study, Regulatory Pathway, Clinical Trial program and Licensing Initiatives |
 | David Brin Member Capital Interface and Management, Technical Support initiatives |
 | Matt Veatch Head of Programs Former Strategic Operations VP, Syneos Health Former Head of Real World Data-Driven Research, Quintiles Pharma Interface, Regulatory Strategy and Pathway management, Clinical Trial and Licensing initiatives |
 | Jason Kralic, PhD - Neuropharmacology Head of Business Development Former Head of CNS Business Development, GlaxoSmithKline Pharma Interface, Regulatory and Clinical Trial initiatives, Licensing |